| 名稱 | BCR-ABL1 Q252H/BaF3 | 
| 型號(hào) | CBP73289 | 
| 報(bào)價(jià) | ![]()  | 
								
| 特點(diǎn) | BCR-ABL1 [Q252H]/BaF3,母細(xì)胞:BaF3,凍存條件:90% FBS+10% DMSO; | 
產(chǎn)品搜索
相關(guān)文章
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
					產(chǎn)品展示  / PRODUCTS
					
						藥靶細(xì)胞株 > kinase激酶細(xì)胞株  >  CBP73289BCR-ABL1 Q252H/BaF3
            
              
					
				
				
						- 詳細(xì)內(nèi)容
 
| CBP73289 | |
| I. Introduction | |
Cell Line Name:  | BCR-ABL1 [Q252H]/BaF3  | 
Host Cell:  | Ba/F3  | 
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) | 
Application:  | Anti-proliferation assay and PD assay  | 
Freeze Medium:  | 90% FBS+10% DMSO  | 
Complete Culture Medium:  | RPMI-1640+10%FBS  | 
Mycoplasma Status:  | Negative  | 
| II.Background | |
ABL1, ABL proto-oncogene 1, non-receptor tyrosine kinase, plays a role in regulation of cell growth through ERK5, Rac/JNK, and Stat1/3 pathways (PMID: 10373409). Fusion proteins of BCR-ABL1 resulting in constitutive kinase activity have been reported in various cancers (PMID: 18851712, PMID: 30125955) and a number of Abl1 mutations in the context of BCR-ABL1 have been demonstrated to confer drug resistance (PMID: 24456693).  | |
| III. Representative Data | |
1.WB of BCR-ABL1 [Q252H]/BaF3 
  | |
2. Sanger of BCR-ABL1 [Q252H]/BaF3 
 Figure 2. BCR-ABL1 [Q252H]/BaF3 Fusion 
 Figure 3. BCR-ABL1 [Q252H]/BaF3 Q252H  | |
3. Anti-proliferation assay  | |
 Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 Q252H Cells (C1).  | |








會(huì)員_a.png)